Skip to main content

New Products

  • Lumene unveils product innovation, new packaging for 2014

    NEW YORK — Finnish beauty brand Lumene is kicking off 2014 with a bang, the company said, as it revamps packaging, broadens its portfolio with new formulas and prepares to expand into Rite Aid stores.

    To highlight the skin care benefits of vitamin C, Lumene’s Vitamin C+ is now known as Bright Now Vitamin C+. The range, which is targeted to women ages 25 years and older, leverages the power of arctic cloudberry nectar and seed oil and vitamin C to brighten and protect the skin while preventing the first signs of aging.

  • MediSafe updates medication reminder app to allow automatic refills

    HAIFA, Israel — Users of a medication-management app can now refill their prescriptions using an enhancement to it.

    MediSafe announced Monday an updated version of its Medication Refill Reminder app allowing users to enter contact information for their preferred pharmacies and, once alerted that a medication refill is needed, to click on the pharmacy logo that directs them to the mobile refill page of the specified pharmacy. The app currently supports refills for Walgreens, CVS, Rite Aid and Health Mart.

  • FDA approves combination of two GSK drugs for skin cancer

    SILVER SPRING, Md. — The Food and Drug Administration has approved two drugs made by GlaxoSmithKline for use together in patients with advanced melanoma that can't be removed by surgery or has spread to other parts of the body, the agency said Friday.

    The FDA announced the new approval for Mekinist (trametinib) and Tafinlar (dabrafenib). The agency originally approved the two drugs for use as single agents for the same indication in May 2013.

  • FDA approves liquid form of Merck HIV drug Isentress for infants, small children

    WHITEHOUSE STATION, N.J. — The Food and Drug Administraiton has approved a liquid formulation of an HIV drug made by Merck, the company said.

    Merck announced the approval of Isentress (raltegravir) for oral suspension, aimed at small children with HIV. The drug may be used by patients as young as four weeks, and the full line of formulations of Isentress now includes the orlal suspension, as well as chewable tablets and film--coated tablets. The company plans to launch the oral suspension in the third quarter of this year.

  • Maloof Ventures launches Never Hungover

    LOS ANGELES — Maloof Ventures announced on Friday the launch of Never Hungover at GNC. Never Hungover is a dietary supplement that is comprised of a natural vitamin blend, antioxidants, amino acids, nutrients and minerals packaged as a 2-oz. serving. 

    The hangover shot is designed to take up to an hour before or while consuming alcohol, and experiences optimal results when taking one bottle per four drinks. 

  • FDA approves generic hypertension pill made by Actavis

    DUBLIN — The Food and Drug Administration has approved a generic drug for high blood pressure made by Actavis, the company said Friday.

    Actavis announced the approval of telmisartan immediate-release tablets in the 20-mg, 40-mg and 80-mg strengths, which it intends to release immediately.

  • Lindt announces new premium chocolates

    STRATHAM, N.H. — Lindt and Sprungli has introduced a bevy of new premium chocolate offerings, with flavor combinations ranging from sweet-and-salty to milk chocolate. 

    The new product offerings include Lindor Coconut truffles, Classic Recipe Caramel with Sea Salt bars, special additions to the Lindt Chocolate Specialties line, and the first-ever Lindt Brownie Mixes.

  • Calorease sets itself apart with active ingredient FBCx

    TORONTO — Soho Flordis is in the process of launching Calorease, a dietary supplement that helps bind to the fat in foods and reduce caloric intake up to 500 calories a day. One of the differentiators setting this diet aid apart from other supplements is the active ingredient — FBCx (α-cyclodextrin), a stimulant-free, heart-healthy fiber. FBCx binds up to nine times its weight in fat from food, safely removing it from the body before it can be absorbed.

X
This ad will auto-close in 10 seconds